Remove 2002 Remove Networking Remove Safety
article thumbnail

Key developments: mRNA vaccines and therapeutics

European Pharmaceutical Review

Robust analytical methods are needed to establish safety, potency, and purity of mRNA therapeutics in large-scale manufacturing. Sarah Bundra, Pharmaceutical Analyst at GlobalData also warned about patient safety: “introducing mRNA carries the risk of activating the immune system.”

article thumbnail

Personalizing the Cancer Patient Journey

Pharma Marketing Network

Sunny White is an editorial advisory board member for the Pharma Marketing Network with hands-on experience helping pharmaceutical marketers elevate their promotional material to meet the unique needs of patients and caregivers while remaining compliant. The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of Medicinal Products.

Patients 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Over the past few years, we have researched the types of evidence used in regulatory decisions for drug product withdrawals due to safety concerns in Europe. But from a safety point of view, observational studies can be more representative of the population the drug will serve. Meta-analyses contributed least frequently (31.4

Medicine 116
article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile. While favourable safety has been reported up to the Phase II, the relevance of targeting the C-terminal portion of Abeta still needs to be confirmed.

article thumbnail

12 Brilliant Healthcare Marketing Campaign Initiatives

Medico Reach

To address the shortage of nurses in the US , Johnson & Johnson started the Nurses’ Future initiative in 2002. In doing so, the Stachie contest was able to leverage social networking sites and increase website traffic for the hospital. ‘Preparing Nurses for The Future’ by Johnson & Johnson.

article thumbnail

The State of the Union in Cancer Innovation

PM360

However, due to conjugation instability and unfavorable safety profiles of currently available ADCs, we can still do more to ensure ADCs are more broadly available and amenable options for the patients who need them. Preliminary data are expected in 2023.

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

More convenience and safety? Fewer Networking & Industry Trade Show Events. As the pandemic ramped up, patients and prescribers ditched their traditional methods of interacting within the office and telemedicine became the new norm. What’s not to love? Higher Travel & Marketing Costs.

Pharma 52